Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > IF there is no PR tomorrow

<< Previous

Bullboard Posts

Next >>

Comment by Momo25on Aug 20, 2023 2:38pm

138 Views

Post# 35597028

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:IF there is no PR tomorrow

Again, SPECEO is on duty. Same song, same B,S.

@ SPECEO, If you believe in what you say, why not averaging down. Your fund had about 3 to 5 millions shares pre-consolidation. It is now about 1 million post consolidation. You're losing 85% of your investment. Here is my advice to you: buy another pack of 1 million and your share average will be down to $13 post-consolidation. In few months you will have a healty portfolio. Show us your courage and your smartness, then we can follow, maybe!!!!
As I said, SPECEO is on duty. Don't trust him anymore. Any word he may say is pure propaganda.

<< Previous

Bullboard Posts

Next >>

Now trading on the TSX Venture Exchange: Kootenay Resources Inc.